Integrated network pharmacology, metabolomics, and microbiome studies to reveal the therapeutic effects of Anacyclus pyrethrum in PD–MCI mice
EEAP holds great promise as a potential therapeutic agent for PD-MCI, exerting its effects through multiple mechanisms, including regulating protein expression, modulating the fecal metabolic profile, and reshaping the gut microbiota and its metabolites.
Authors
- Ying Liang (ORCID: https://orcid.org/0000-0002-6216-4743)
- Qian Wu (ORCID: https://orcid.org/0009-0000-4342-6974)
- Yan Chen (ORCID: https://orcid.org/0000-0003-4885-9378)
- Pei Li (ORCID: https://orcid.org/0000-0001-7276-6337)
- Xin Yang (ORCID: https://orcid.org/0000-0003-2425-6257)
- Yu Yong
- Munire Shataer
- Tayier Tuersong
- Samire Shataer
Institutions
- Xinjiang Medical University (CN)
- Second Affiliated Hospital of Xinjiang Medical University (CN)
Publication Details
- Journal
- Phytomedicine
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1016/j.phymed.2025.156729
- Citations
- 5
- Primary Topic
- Herbal Medicine Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 11.91